GALT$3.432.85%0.095
Galectin Therapeutics Inc (GALT)
Date: 2026-11-03 16:00O: 3.33H: 3.43L: 3.33C: 3.43Vol: 5.494k
Galectin Therapeutics Inc stock is traded at $3.43, with a volume of 5,316. It is up +2.85% in the last 24 hours and down -12.18% over the past month. Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
Previous Close:
$3.33
Open:
$3.33
24h Volume:
5,316
Relative Volume:
0.03
Market Cap:
$345.41M
Revenue:
-
Net Income/Loss:
-$26.25M
P/E Ratio:
-
EPS:
-$0.4099
Net Cash Flow:
-$20.05M
1W Performance:
+1.33%
1M Performance:
-12.18%
6M Performance:
+50.88%
1Y Performance:
-42.92%
1-Day Range:
$3.33$3.43
1-Week Range:
$3.27$3.70
52-Week Range:
$2.03$7.13
Galectin Therapeutics Inc Stock (GALT) Company Profile
Name
Galectin Therapeutics IncSector
HealthcareIndustry
BiotechnologyPhone
678-620-3186Address
4960 PEACHTREE INDUSTRIAL BOULEVARD, NORCROSS, GA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS
Galectin Therapeutics Inc Stock (GALT) Upgrades & Downgrades
Galectin Therapeutics Inc Stock (GALT) Financials Data
Galectin Therapeutics Inc Stock (GALT) Insider Trading
- Uihlein Richard EJul 31 '26Director
- Transaction
- Option Exercise
- Cost
- $3.08
- #Shares
- 34,376,167
- Value ($)
- 105,806,980
- #Shares Total
- 44,713,843
- Jamil KhurramJul 14 '26Chief Medical Officer
- Transaction
- Sale
- Cost
- $5.13
- #Shares
- 16,250
- Value ($)
- 83,284
- #Shares Total
- 0
- Jamil KhurramJul 14 '26Chief Medical Officer
- Transaction
- Option Exercise
- Cost
- $3.04
- #Shares
- 16,250
- Value ($)
- 49,400
- #Shares Total
- 16,250
- Shlevin Harold H.Jun 29 '26Director
- Transaction
- Sale
- Cost
- $5.04
- #Shares
- 22,268
- Value ($)
- 112,231
- #Shares Total
- 6,500
- Jamil KhurramJun 29 '26Chief Medical Officer
- Transaction
- Sale
- Cost
- $5.04
- #Shares
- 47,467
- Value ($)
- 239,234
- #Shares Total
- 0
- Shlevin Harold H.Jun 29 '26Director
- Transaction
- Option Exercise
- Cost
- $1.23
- #Shares
- 22,268
- Value ($)
- 27,390
- #Shares Total
- 28,768
- Harold ShlevinJun 29 '26Director
- Transaction
- Proposed Sale
- Cost
- $5.04
- #Shares
- 22,268
- Value ($)
- 112,212
- #Shares Total
- 0
- Jamil KhurramJun 29 '26Chief Medical Officer
- Transaction
- Option Exercise
- Cost
- $2.50
- #Shares
- 47,467
- Value ($)
- 118,668
- #Shares Total
- 47,467
- Jamil KhurramJun 26 '26Chief Medical Officer
- Transaction
- Option Exercise
- Cost
- $2.37
- #Shares
- 4,570
- Value ($)
- 10,814
- #Shares Total
- 2,533
- Jamil KhurramJun 26 '26Chief Medical Officer
- Transaction
- Sale
- Cost
- $5.00
- #Shares
- 4,570
- Value ($)
- 22,850
- #Shares Total
- 0
